These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 25526030)
1. Inhibition of Lon blocks cell proliferation, enhances chemosensitivity by promoting apoptosis and decreases cellular bioenergetics of bladder cancer: potential roles of Lon as a prognostic marker and therapeutic target in baldder cancer. Liu Y; Lan L; Huang K; Wang R; Xu C; Shi Y; Wu X; Wu Z; Zhang J; Chen L; Wang L; Yu X; Zhu H; Lu B Oncotarget; 2014 Nov; 5(22):11209-24. PubMed ID: 25526030 [TBL] [Abstract][Full Text] [Related]
2. Mitochondrial Lon is over-expressed in high-grade gliomas, and mediates hypoxic adaptation: potential role of Lon as a therapeutic target in glioma. Di K; Lomeli N; Wood SD; Vanderwal CD; Bota DA Oncotarget; 2016 Nov; 7(47):77457-77467. PubMed ID: 27764809 [TBL] [Abstract][Full Text] [Related]
3. Down-regulating overexpressed human Lon in cervical cancer suppresses cell proliferation and bioenergetics. Nie X; Li M; Lu B; Zhang Y; Lan L; Chen L; Lu J PLoS One; 2013; 8(11):e81084. PubMed ID: 24260536 [TBL] [Abstract][Full Text] [Related]
4. Effect of Lon protease knockdown on mitochondrial function in HeLa cells. Bayot A; Gareil M; Chavatte L; Hamon MP; L'Hermitte-Stead C; Beaumatin F; Priault M; Rustin P; Lombès A; Friguet B; Bulteau AL Biochimie; 2014 May; 100():38-47. PubMed ID: 24355201 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of TFAM inhibits the tumorigenesis of non-small cell lung cancer by activating ROS-mediated JNK/p38MAPK signaling and reducing cellular bioenergetics. Xie D; Wu X; Lan L; Shangguan F; Lin X; Chen F; Xu S; Zhang Y; Chen Z; Huang K; Wang R; Wang L; Song X; Liu Y; Lu B Oncotarget; 2016 Mar; 7(10):11609-24. PubMed ID: 26820294 [TBL] [Abstract][Full Text] [Related]
6. Mitochondrial Lon protease controls ROS-dependent apoptosis in cardiomyocyte under hypoxia. Kuo CY; Chiu YC; Lee AY; Hwang TL Mitochondrion; 2015 Jul; 23():7-16. PubMed ID: 25922169 [TBL] [Abstract][Full Text] [Related]
7. Mitochondrial Lon Protease and Cancer. Lu B Adv Exp Med Biol; 2017; 1038():173-182. PubMed ID: 29178076 [TBL] [Abstract][Full Text] [Related]
8. Intermittent hypoxia leads to functional reorganization of mitochondria and affects cellular bioenergetics in marine molluscs. Ivanina AV; Nesmelova I; Leamy L; Sokolov EP; Sokolova IM J Exp Biol; 2016 Jun; 219(Pt 11):1659-74. PubMed ID: 27252455 [TBL] [Abstract][Full Text] [Related]
9. The mitochondrial ATP-dependent Lon protease: a novel target in lymphoma death mediated by the synthetic triterpenoid CDDO and its derivatives. Bernstein SH; Venkatesh S; Li M; Lee J; Lu B; Hilchey SP; Morse KM; Metcalfe HM; Skalska J; Andreeff M; Brookes PS; Suzuki CK Blood; 2012 Apr; 119(14):3321-9. PubMed ID: 22323447 [TBL] [Abstract][Full Text] [Related]
10. Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells. Gibellini L; Pinti M; Boraldi F; Giorgio V; Bernardi P; Bartolomeo R; Nasi M; De Biasi S; Missiroli S; Carnevale G; Losi L; Tesei A; Pinton P; Quaglino D; Cossarizza A FASEB J; 2014 Dec; 28(12):5122-35. PubMed ID: 25154874 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of the human Lon protease impairs mitochondrial structure and function and causes cell death. Bota DA; Ngo JK; Davies KJ Free Radic Biol Med; 2005 Mar; 38(5):665-77. PubMed ID: 15683722 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of Lon contributes to survival and aggressive phenotype of cancer cells through mitochondrial complex I-mediated generation of reactive oxygen species. Cheng CW; Kuo CY; Fan CC; Fang WC; Jiang SS; Lo YK; Wang TY; Kao MC; Lee AY Cell Death Dis; 2013 Jun; 4(6):e681. PubMed ID: 23788038 [TBL] [Abstract][Full Text] [Related]
14. Lon Peptidase 2, Peroxisomal (LONP2) Contributes to Cervical Carcinogenesis via Oxidative Stress. Wu W; Liu F; Wu K; Chen Y; Wu H; Dai G; Zhang W Med Sci Monit; 2018 Mar; 24():1310-1320. PubMed ID: 29502128 [TBL] [Abstract][Full Text] [Related]
15. Mitochondrial Lon protease - depleted HeLa cells exhibit proteome modifications related to protein quality control, stress response and energy metabolism. Hamon MP; Gergondey R; L'honoré A; Friguet B Free Radic Biol Med; 2020 Feb; 148():83-95. PubMed ID: 31904544 [TBL] [Abstract][Full Text] [Related]
16. Ursolic acid-induced AMP-activated protein kinase (AMPK) activation contributes to growth inhibition and apoptosis in human bladder cancer T24 cells. Zheng QY; Jin FS; Yao C; Zhang T; Zhang GH; Ai X Biochem Biophys Res Commun; 2012 Mar; 419(4):741-7. PubMed ID: 22387548 [TBL] [Abstract][Full Text] [Related]
17. Altholactone induces reactive oxygen species-mediated apoptosis in bladder cancer T24 cells through mitochondrial dysfunction, MAPK-p38 activation and Akt suppression. Zhao B; Li X Oncol Rep; 2014 Jun; 31(6):2769-75. PubMed ID: 24700345 [TBL] [Abstract][Full Text] [Related]
18. Stress-activated kinase pathway alteration is a frequent event in bladder cancer. Otto KB; Acharya SS; Robinson VL Urol Oncol; 2012; 30(4):415-20. PubMed ID: 22154358 [TBL] [Abstract][Full Text] [Related]
19. Inactivation of brain mitochondrial Lon protease by peroxynitrite precedes electron transport chain dysfunction. Stanyer L; Jorgensen W; Hori O; Clark JB; Heales SJ Neurochem Int; 2008 Sep; 53(3-4):95-101. PubMed ID: 18598728 [TBL] [Abstract][Full Text] [Related]
20. Mitochondrial Lon protease at the crossroads of oxidative stress, ageing and cancer. Pinti M; Gibellini L; Liu Y; Xu S; Lu B; Cossarizza A Cell Mol Life Sci; 2015 Dec; 72(24):4807-24. PubMed ID: 26363553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]